Company intelligence / Profile preview

ByteMD

Ownership: Private
Development stage: Commercial

Overview

ByteMD offers a personalized gastrointestinal symptom tracker app designed to help users monitor digestive symptoms and dietary triggers. The platform provides educational resources and community support for individuals managing gut health issues. It does not develop drugs or biologics but focuses on digital tools for patient empowerment in digestive wellness[2].

Therapeutic areas: GastroenterologyMetabolic Disorders
Modalities: Non-pharmacological therapyDigital health platform (app-based symptom tracking)
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on ByteMD.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ByteMD.

Explore the full profile